Your browser doesn't support javascript.
loading
Development of an Intranasal Gel for the Delivery of a Broadly Acting Subunit Influenza Vaccine.
Varma, Devika M; Batty, Cole J; Stiepel, Rebeca T; Graham-Gurysh, Elizabeth G; Roque, John A; Pena, Erik S; Hasan Zahid, M Shamim; Qiu, Kunyu; Anselmo, Aaron; Hill, David B; Ross, Ted M; Bachelder, Eric M; Ainslie, Kristy M.
Afiliação
  • Varma DM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Batty CJ; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Stiepel RT; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Graham-Gurysh EG; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Roque JA; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Pena ES; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina 27599, United States.
  • Hasan Zahid MS; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Qiu K; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Anselmo A; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Hill DB; Department of Physics and Astronomy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Ross TM; Marsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Bachelder EM; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia 30605, United States.
  • Ainslie KM; Department of Infectious Diseases, University of Georgia, Athens, Georgia 30605, United States.
ACS Biomater Sci Eng ; 8(4): 1573-1582, 2022 04 11.
Article em En | MEDLINE | ID: mdl-35353486
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Infecções por Orthomyxoviridae / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Limite: Animals / Female / Humans Idioma: En Revista: ACS Biomater Sci Eng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Infecções por Orthomyxoviridae / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Limite: Animals / Female / Humans Idioma: En Revista: ACS Biomater Sci Eng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos